Videos

Benefits of Dual Treatment for MCL

12/09/2020

Constantine Tam, MD, director of Hematology, St Vincent Hospital, discusses the phase 3 SYMPATICO study that examined the use ibrutinib plus venetoclax for the treatment of mantle cell lymphoma.

What's Trending?

News

Featured Sessions at AHS 2018

11/14/2018

The Scottsdale Headache Symposium offers a variety of sessions and educational objectives to help attendees gain a better understanding of headache treatment.

The Scottsdale Headache...

11/14/2018

First Report Managed Care

News

Merck Immunotherapy Appears Effective in Head and Neck Cancer

05/29/2015

A Merck drug that helps the immune system fight cancer was about twice as effective as the current standard therapy for patients with recurrent or advanced head and neck cancers, according to study data released on Friday.

A Merck drug that helps the...

05/29/2015

Pharmacy Learning Network

News

Survey: Fewer doctors taking freebies from drug companies

11/09/2010

First Report Managed Care

News

Benefits of CD30 CAR-T Therapy for Multiply Relapsed Enteropathy-Associated T-Cell Lymphoma

12/10/2020

In a recent case study, CAR-T therapy targeting the CD30 molecule promoted a durable remission in a patient with multiply relapsed enteropathy-associated T-cell lymphoma after previous allogeneic stem cell transplantation.

In a recent case study, CAR-T...

12/10/2020

First Report Managed Care

News

US Pharma Prices Increase by 9.8% in Past Year

07/18/2016

More than two-thirds of the 20 largest pharmaceutical companies, including Pfizer, Biogen, Gilead Sciences, Amgen, and AbbVie, have boosted their sales in the first quarter of 2016 by increasing prices on their biggest products.

Benefits of Dual Treatment for MCL

What's Trending?

Stay Informed—Sign up today!

Specialties

Events

Year Round Education

HMP Global Products